3 In the REIMAGINE 1 trial, the most commonly reported adverse events (AEs) were gastrointestinal (GI)-related, occurring in 33/62 (53%) participants in the CagriSema 2.4 mg/2.4 mg group, 28/63 (44%) participants in the CagriSema 1 mg/1 mg group, and 13/64 (20%) participants in the placebo group
Ask your doctor about protein recommendations before starting Mounjaro
Limit liquid sugar and fructose-heavy inputs , this is a common lever on hepatic de novo lipogenesis
A key challenge is optimizing the bioavailability and pharmacokinetics of these compounds for oral administration in humans
Some researchers add 30-90 units of water to each dose specifically to reduce local inflammation
However, the effects on BMI, fasting blood glucose, lipid profiles, hormonal levels, and PCOS-related symptoms such as acne and hirsutism were inconsistent